-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Rani Therapeutics Holdings, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2021 to Q4 2024.
- Rani Therapeutics Holdings, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 28.5M shares, a 11.6% increase year-over-year.
- Rani Therapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 28.5M shares, a 11.6% increase from 2023.
- Rani Therapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 25.5M shares, a 7.09% increase from 2022.
- Rani Therapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 23.8M shares.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)